178 related articles for article (PubMed ID: 8447345)
1. How to ask drug companies for help.
Hayes JD
Am J Nurs; 1993 Jan; 93(1):38-41. PubMed ID: 8447345
[No Abstract] [Full Text] [Related]
2. Regulating manufacturer-affiliated communication in the information age.
Schulman KA; Abernethy DR; Rathore SS; Woosley RL
Clin Pharmacol Ther; 1999 Jun; 65(6):593-7. PubMed ID: 10391664
[No Abstract] [Full Text] [Related]
3. Reimbursement of drug cost-medical assistance program.
Hosp Formul; 1975 Mar; 10(3):120, 122, 142. PubMed ID: 10297178
[No Abstract] [Full Text] [Related]
4. Should you let the FDA decide what drugs you pay for?
Dutton G
Bus Health; 1996 Oct; 14(10):65, 69-70, 73. PubMed ID: 10161492
[No Abstract] [Full Text] [Related]
5. Stimulating pharmaceutical innovation.
Levy R
Issues Sci Technol; 1990-1991 Winter; 7(2):35-7. PubMed ID: 10108816
[No Abstract] [Full Text] [Related]
6. The role of the state as a drug purchaser.
Palumbo FB
Food Drug Law J; 2001; 56(3):267-80. PubMed ID: 11944639
[No Abstract] [Full Text] [Related]
7. Analysis of factors influencing antibiotic usage in hospitals.
Sabath LD; Notto DA
Prog Clin Biol Res; 1979; 35():65-74. PubMed ID: 538037
[No Abstract] [Full Text] [Related]
8. Incentives in the Medicare prescription drug benefit.
Natl Bur Econ Res Bull Aging Health; 2006; (15):1-2. PubMed ID: 16805056
[No Abstract] [Full Text] [Related]
9. How do pharmaceutical companies handle consumer adverse drug reaction reports? An overview based on a survey of French drug safety managers and officers.
Fleuranceau-Morel P
Pharmacoepidemiol Drug Saf; 2002; 11(1):37-44. PubMed ID: 11998550
[TBL] [Abstract][Full Text] [Related]
10. States combat drug costs.
Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
[No Abstract] [Full Text] [Related]
11. Pharmacy costs: your home state may help out.
Shapiro JP
US News World Rep; 2000 Dec; 129(23):84-5. PubMed ID: 11126062
[No Abstract] [Full Text] [Related]
12. Pharmaceutical manufacturers ... leaving tradition behind and forging new managed care alliances.
Barnett AA
State Health Care Am; 1995; ():41-6. PubMed ID: 10168072
[No Abstract] [Full Text] [Related]
13. Medicaid program; time limitation on recordkeeping requirements under the drug rebate program. Final rule.
Centers for Medicare & Medicaid Services (CMS), HHS
Fed Regist; 2004 Nov; 69(227):68815-8. PubMed ID: 15565749
[TBL] [Abstract][Full Text] [Related]
14. What a Food and Drug lawyer should know about the Medicare Modernization Act.
Azar AM
Food Drug Law J; 2004; 59(2):217-22. PubMed ID: 15318393
[No Abstract] [Full Text] [Related]
15. Principal findings from the Washington State cognitive services demonstration project.
Christensen DB; Holmes G; Fassett WE; Neil N; Andrilla CH; Smith DH; Andrews A; Bell EJ; Hansen R; Shafer R; Stergachis A
Manag Care Interface; 1998 Jul; 11(7):60-2, 64. PubMed ID: 10181572
[TBL] [Abstract][Full Text] [Related]
16. Drug companies crying foul over Medicaid's formulary push.
Carroll J
Manag Care; 2002 Nov; 11(11):12-4. PubMed ID: 12491852
[No Abstract] [Full Text] [Related]
17. Unraveling the ramifications of recent pharmaceutical industry acquisitions by looking at the past, present and future of PBMs (pharmacy benefit management firms).
Herzfeld JD
Empl Benefits J; 1995 Mar; 20(1):20-3, 30. PubMed ID: 10142515
[No Abstract] [Full Text] [Related]
18. Abolition of Pharmaceutical Reimbursement Advisory Committee: final regulation.
Fed Regist; 1978 Aug; 43(154):35310-1. PubMed ID: 10297140
[No Abstract] [Full Text] [Related]
19. Barrier to trade or barrier to profit? Why Australia's Pharmaceutical Benefits Scheme worries U.S. drug companies.
Hamilton C; Lokuge B; Denniss R
Yale J Health Policy Law Ethics; 2004; 4(2):373-85. PubMed ID: 15536919
[No Abstract] [Full Text] [Related]
20. Medicare should bargain for lower drug prices, study says.
Med Health; 2005 Oct; 59(36):1, 3, 7. PubMed ID: 16240494
[No Abstract] [Full Text] [Related]
[Next] [New Search]
